ResMed finishes year with singe-digit increases
SAN DIEGO – ResMed reported revenues of $453.1 million for the fourth quarter ended June 30, 2015, a 9% increase compared to the same quarter last year. It reported a net income of $87.5 million, consistent with the same quarter last year. ResMed reported revenues of $1.7 billion for fiscal year 2015, an 8% increase compared to last year. It reported a net income of $352.9 million, a 2% increase. For the Americas, ResMed reported revenues of $273.7 million for the fourth quarter, a 27% increase compared to the same period last year. Results for the fourth quarter were impacted by two non-recurring items: expenses of $5 million associated with the field safety notice in response to results of the Serve-HF clinical trial; and donations of $6 million ($5 million to the University of California-San Diego to fund a center of excellence and endowed chair in the field of pulmonary and critical care medicine, and an incremental donation of $1 million to the ResMed Foundation).